APOC3 and type 2 diabetes mellitus: Genetically predicted LPL activation was associated with lower risk of T2D (OR = 0.80, 95% CI=0.73 to 0.87, P=2.0e-07), but this was not found for APOC3 inhibition (OR = 0.92, 95% CI=0.85 to 1.00, p=0.058).